Recent developments in ruthenium anticancer drugs
Abstract
Interest in Ru anticancer drugs has been growing rapidly since
Maintenance work is planned for Wednesday 1st May 2024 from 9:00am to 11:00am (BST).
During this time, the performance of our website may be affected - searches may run slowly and some pages may be temporarily unavailable. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
E-mail:
p.lay@chem.usyd.edu.au
Fax: +61-2-93513329
Tel: +61-2-93514269
Interest in Ru anticancer drugs has been growing rapidly since
Fetching data from CrossRef.
This may take some time to load.
Loading related content